Territorial Availability: Available through Bertin Technologies only in France Cayman Chemicals mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health
Hallmann J., Daub, M, Wesemael W
E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2491 - ESOC25-756 INFLUENCE OF OBSTRUCTIVE SLEEP APNEA ON CARDIOEMBOLIC STROKE SEVERITY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Lina Zubalova 1 , Lilit Minasyan 1 , Marine Balasanyan 1 , Manya Margaryan 1 , Oganes Ezoyan 1 , Lusine Madoyan 1 , David Sahakyan 1 , Aleksan Petrosyan 1 , David Margaryan 1 , Nune Yeghiazaryan 1 , Samson Khachatryan 2 , Manvel Aghasaryan 3 1 "Erebouni" MC, Yerevan, Armenia, 2 Department of Neurology and Neurosurgery, National Institute of Health, "Somnus" Neurology Clinic, Yerevan, Armenia, 3 Sud Francilien Hospital, Corbeil-Essonnes, Paris Region, France Background and Aims: Obstructive sleep apnea (OSA) in the acute phase of a stroke may negatively impact patients' outcomes with AF-related cardioembolic stroke
They identified 93 cases associated with regional anesthesia
Encontre o que procura